Bradley Paul Morgan is VP at CYTOKINETICS INC (CYTK). They have made 1 open-market trade across 1 company since 2017, most recently 2017-08-31.
CIK 0001659025
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CYTK | 47,520 | $2.9M |
Shares reported on the most recent Form 4, priced at the 2017-09-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYTK | SELL | 2017-08-31 | 2017-09-01 | $15.00 | $1.8M | -7.8% | +0.7% | -41.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.